Cortexyme
ID: 5305564Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California.
4
Funding Rounds
$278.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca*** Ly*** | - | - | |
| St*** Do**** | - | - | - |
| Kr***** Ga**** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Un* Ry** | - | - | - |
| Ph**** Lo* | - | - | |
| Di** Th** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cortexyme has raised a total of $202m in funding over 4 rounds.
Key Insights:
- Cortexyme Private equity, February 2020: $125m
- Cortexyme Series B round, May 2018: $76m
- Cortexyme Seed round, October 2014: $1m
- Cortexyme, Inc. funding round, June 2018: $76m
Industries
Cortexyme is active in the following industries: